Posts by: Malika Ammam, PhD

News

Dantrolene could be a new therapeutic agent to improve neurological function and disease symptoms in neuropathic Gaucher disease (nGD), according to a collaborative research study developed on a mice model ... Read more

June 21, 2016

Taliglucerase Alfa Seen as an Effective And Safe Long-Term Treatment for Gaucher Disease

News

Researchers investigating the long-term efficacy and safety of taliglucerase alfa in treatment-naïve adults with Gaucher disease (GD) reported that the drug provided clinical benefits without new or severe side effects. The study, “Long-term ... Read more

June 17, 2016June 17, 2016

Dr. Roscoe Brady, Pioneer Scientist in Gaucher Disease, Dies at 92

News

Dr. Roscoe Owen Brady, a long honored pioneer for enzyme therapeutic approaches in treating metabolic disorders including Gaucher disease, has died. Brady, bolstered by his own unlimited devotion and persistance ... Read more

May 27, 2016May 27, 2016

Study Reports Two Novel Mutations of Gaucher Disease Type 1

News

A team of researchers led by the University of Victoria, British Columbia, have recently identified two novel mutation sites characteristic of Gaucher Disease Type 1 (GD1). The findings, “Identification of ... Read more

May 26, 2016May 26, 2016

Study Compares Biochemical Outcomes of Gaucher Disease Type 1 Patients to Selected Therapies

News

The biochemical responses in patients with Gaucher disease type I (GD1) treated with some selected therapeutic options have been compared in a study, “Biochemical response to substrate reduction therapy versus ... Read more

May 24, 2016May 24, 2016

Study of Gaucher Disease in Iraqi Children Sheds Light on Treatment Best Practices

News

The diagnostic and therapeutic approaches in children living in Iraq with Gaucher disease (GD) were recently evaluated in a study, “Gaucher disease in Iraqi children (Clinical, diagnostic & therapeutic aspects),” published ... Read more

May 23, 2016May 23, 2016

Recommended Uses of Eliglustat in Gaucher Disease Type 1 Explored in New Study

News

A team of researchers recently discussed the recommended uses of the drug eliglustat in American adults suffering from Gaucher disease type 1 (GD1). These findings, “Recommendations for the use of ... Read more